Literature DB >> 27503097

Prodromal symptoms of Parkinson's disease: Implications for epidemiological studies of disease etiology.

A Elbaz1.   

Abstract

In recent years, there has been a major shift in our understanding of the course of Parkinson's disease (PD) from a disease of the brain to a disease of long latency, characterized by the progressive emergence of multiple non-motor symptoms, including hyposmia, constipation, depression, anxiety, rapid eye movement (REM) sleep behavior disorder and excessive daytime sleepiness, as well as subtle motor signs, before the typical motor signs appear. Epidemiological studies have made major contributions by allowing better characterization of subsequent PD risk in relation to non-motor symptoms. Such findings have profound implications for the conduct of epidemiological studies examining risk and protective factors in PD, and the interpretation of their findings. Given the length of the prodromal period, reverse causation in particular is a major concern with many reported associations. One striking feature of PD etiology, compared with other diseases, is the presence of numerous inverse associations. If these associations are truly causal, they would have major implications for disease prevention and for slowing disease progression. However, whether these associations are truly causal remains to be demonstrated in future studies. Experimental studies play an important role by offering a better understanding of the underlying mechanisms. Well-designed epidemiological studies using innovative approaches will also be key in elucidating whether these intriguing associations are causal or a consequence of reverse causation.
Copyright © 2016 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Causalité inverse; Epidemiology; Facteurs de risque; Maladie de Parkinson; Non-motor symptoms; Parkinson's disease; Reverse causation; Risk factors; Symptômes non-moteurs; Épidémiologie

Mesh:

Year:  2016        PMID: 27503097     DOI: 10.1016/j.neurol.2016.07.001

Source DB:  PubMed          Journal:  Rev Neurol (Paris)        ISSN: 0035-3787            Impact factor:   2.607


  8 in total

Review 1.  Premotor Diagnosis of Parkinson's Disease.

Authors:  Heinz Reichmann
Journal:  Neurosci Bull       Date:  2017-08-03       Impact factor: 5.203

2.  Incidence of Parkinson's disease in French women from the E3N cohort study over 27 years of follow-up.

Authors:  Marianne Canonico; Fanny Artaud; Isabelle Degaey; Frédéric Moisan; Rahime Kabore; Berta Portugal; Thi Thu Ha Nguyen; Giancarlo Pesce; Marie-Christine Boutron-Ruault; Emmanuel Roze; Alexis Elbaz
Journal:  Eur J Epidemiol       Date:  2022-03-14       Impact factor: 8.082

3.  Mendelian Randomisation Study of Smoking, Alcohol, and Coffee Drinking in Relation to Parkinson's Disease.

Authors:  Cloé Domenighetti; Pierre-Emmanuel Sugier; Ashwin Ashok Kumar Sreelatha; Claudia Schulte; Sandeep Grover; Océane Mohamed; Berta Portugal; Patrick May; Dheeraj R Bobbili; Milena Radivojkov-Blagojevic; Peter Lichtner; Andrew B Singleton; Dena G Hernandez; Connor Edsall; George D Mellick; Alexander Zimprich; Walter Pirker; Ekaterina Rogaeva; Anthony E Lang; Sulev Koks; Pille Taba; Suzanne Lesage; Alexis Brice; Jean-Christophe Corvol; Marie-Christine Chartier-Harlin; Eugénie Mutez; Kathrin Brockmann; Angela B Deutschländer; Georges M Hadjigeorgiou; Efthimos Dardiotis; Leonidas Stefanis; Athina Maria Simitsi; Enza Maria Valente; Simona Petrucci; Stefano Duga; Letizia Straniero; Anna Zecchinelli; Gianni Pezzoli; Laura Brighina; Carlo Ferrarese; Grazia Annesi; Andrea Quattrone; Monica Gagliardi; Hirotaka Matsuo; Yusuke Kawamura; Nobutaka Hattori; Kenya Nishioka; Sun Ju Chung; Yun Joong Kim; Pierre Kolber; Bart Pc van de Warrenburg; Bastiaan R Bloem; Jan Aasly; Mathias Toft; Lasse Pihlstrøm; Leonor Correia Guedes; Joaquim J Ferreira; Soraya Bardien; Jonathan Carr; Eduardo Tolosa; Mario Ezquerra; Pau Pastor; Monica Diez-Fairen; Karin Wirdefeldt; Nancy L Pedersen; Caroline Ran; Andrea C Belin; Andreas Puschmann; Clara Hellberg; Carl E Clarke; Karen E Morrison; Manuela Tan; Dimitri Krainc; Lena F Burbulla; Matt J Farrer; Rejko Krüger; Thomas Gasser; Manu Sharma; Alexis Elbaz
Journal:  J Parkinsons Dis       Date:  2022       Impact factor: 5.520

4.  Pooled analysis of the HLA-DRB1 by smoking interaction in Parkinson disease.

Authors:  Yu-Hsuan Chuang; Pei-Chen Lee; Tim Vlaar; Claire Mulot; Marie-Anne Loriot; Johnni Hansen; Christina M Lill; Beate Ritz; Alexis Elbaz
Journal:  Ann Neurol       Date:  2017-10-26       Impact factor: 10.422

Review 5.  Biological and Clinical Implications of Comorbidities in Parkinson's Disease.

Authors:  Jose A Santiago; Virginie Bottero; Judith A Potashkin
Journal:  Front Aging Neurosci       Date:  2017-12-04       Impact factor: 5.750

6.  Detecting Non-cognitive Features of Prodromal Neurodegenerative Diseases.

Authors:  Alon Seifan; Christine A Ganzer; Krista Ryon; Michael Lin; Rahman Mahmudur; Henriquez Adolfo; Cindy Shih; Alan R Jacobs; Molly Greenwald; Richard S Isaacson
Journal:  Curr Aging Sci       Date:  2019

Review 7.  Perspective: Current Pitfalls in the Search for Future Treatments and Prevention of Parkinson's Disease.

Authors:  Peter C Poortvliet; Karen O'Maley; Peter A Silburn; George D Mellick
Journal:  Front Neurol       Date:  2020-07-08       Impact factor: 4.003

Review 8.  Parkinson's Disease and Melanoma: Co-Occurrence and Mechanisms.

Authors:  Anindita Bose; Gregory A Petsko; David Eliezer
Journal:  J Parkinsons Dis       Date:  2018       Impact factor: 5.568

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.